St. Louis, MO, United States of America

Theresa L Murphy

This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignee: Washington University. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theresa L Murphy. Retrieved from https://idiyas.com/inventor/theresa-l-murphy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2007-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Theresa L. Murphy

Introduction

Theresa L. Murphy is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of immunology, particularly in the modulation of lymphocyte activity. With a total of 4 patents, her work has implications for therapeutic, diagnostic, and research purposes.

Latest Patents

One of her latest patents is titled "Compositions and methods for modulating lymphocyte activity." This invention introduces a novel lymphocyte inhibitory receptor known as BTLA, which is expressed on both T and B cells. The patent identifies HVEM as an interacting partner with BTLA. Additionally, it provides methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM.

Career Highlights

Theresa L. Murphy is affiliated with Washington University, where she continues her research and innovation in the field of immunology. Her work has garnered attention for its potential to advance therapeutic strategies in immune modulation.

Collaborations

Some of her notable coworkers include Norihiko Watanabe and Jianfei Yang, who contribute to her research endeavors.

Conclusion

Theresa L. Murphy's innovative work in lymphocyte modulation showcases her expertise and commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…